These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36192196)

  • 1. Prediction of Sudden Cardiac Arrest After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: ASA-SCARRE Risk Score.
    Veselka J; Liebregts M; Cooper R; Faber L; Januska J; Kashtanov M; Tesarkova KH; Hansen PR; Seggewiss H; Shloydo E; Popov K; Hansvenclova E; Polakova E; Ten Berg J; Stables RH; Jarkovsky J; Bonaventura J
    Am J Cardiol; 2022 Dec; 184():120-126. PubMed ID: 36192196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term outcome after alcohol septal ablation in obstructive hypertrophic cardiomyopathy: Experience of a reference center.
    Aguiar Rosa S; Fiarresga A; Galrinho A; Cacela D; Ramos R; de Sousa L; Gonçalves A; Bernardes L; Patrício L; Branco LM; Ferreira RC
    Rev Port Cardiol (Engl Ed); 2019 Jul; 38(7):473-480. PubMed ID: 31495717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of left ventricular mass, left atrial size, and N-terminal pro-B-type natriuretic peptide level following alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Dąbrowski M; Kukuła K; Kłopotowski M; Bekta P; Śpiewak M; Mazurkiewicz Ł; Tyczyński P; Orczykowski M; Parma R; Witkowski A
    Kardiol Pol; 2019; 77(2):181-189. PubMed ID: 30566209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Almasood A; Garceau P; Woo A; Rakowski H; Schwartz L; Overgaard CB
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1030-4. PubMed ID: 21939945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study.
    Lu M; Du H; Gao Z; Song L; Cheng H; Zhang Y; Yin G; Chen X; Ling J; Jiang Y; Wang H; Li J; Huang J; He Z; Zhao S
    Circ Cardiovasc Interv; 2016 Mar; 9(3):e002675. PubMed ID: 26884612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy.
    Rigopoulos AG; Daci S; Pfeiffer B; Papadopoulou K; Neugebauer A; Seggewiss H
    Clin Res Cardiol; 2016 Nov; 105(11):953-961. PubMed ID: 27270758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Safe and Apparently Efficacious But Does Reporting of Aggregate Outcomes Hide Less-Favorable Results, Experienced by a Substantial Proportion of Patients?
    Cooper RM; Shahzad A; McShane J; Stables RH
    J Invasive Cardiol; 2015 Jul; 27(7):301-8. PubMed ID: 26136275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: low incidence of sudden cardiac death and reduced risk profile.
    Jensen MK; Prinz C; Horstkotte D; van Buuren F; Bitter T; Faber L; Bundgaard H
    Heart; 2013 Jul; 99(14):1012-7. PubMed ID: 23644300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry.
    Veselka J; Jensen MK; Liebregts M; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Tomasov P; Adlova R; Bundgaard H; Steggerda R; Ten Berg J; Faber L
    Eur Heart J; 2016 May; 37(19):1517-23. PubMed ID: 26746632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.
    Alabdaljabar MS; Cendrowski EE; Nishimura RA; Miranda WR; Geske JB; Rihal CS; Eleid MF
    Circ Cardiovasc Interv; 2023 Aug; 16(8):e013068. PubMed ID: 37582173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
    Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
    Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk and Causes of Death in Patients After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.
    Veselka J; Zemánek D; Jahnlová D; Krejčí J; Januška J; Dabrowski M; Bartel T; Tomašov P
    Can J Cardiol; 2015 Oct; 31(10):1245-51. PubMed ID: 26095933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy.
    Miron A; Lafreniere-Roula M; Steve Fan CP; Armstrong KR; Dragulescu A; Papaz T; Manlhiot C; Kaufman B; Butts RJ; Gardin L; Stephenson EA; Howard TS; Aziz PF; Balaji S; Ladouceur VB; Benson LN; Colan SD; Godown J; Henderson HT; Ingles J; Jeewa A; Jefferies JL; Lal AK; Mathew J; Jean-St-Michel E; Michels M; Nakano SJ; Olivotto I; Parent JJ; Pereira AC; Semsarian C; Whitehill RD; Wittekind SG; Russell MW; Conway J; Richmond ME; Villa C; Weintraub RG; Rossano JW; Kantor PF; Ho CY; Mital S
    Circulation; 2020 Jul; 142(3):217-229. PubMed ID: 32418493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.
    van Ramshorst J; Mollema SA; Delgado V; van der Wall EE; Schalij MJ; Atsma DE; Bax JJ
    Am J Cardiol; 2009 Jun; 103(11):1592-7. PubMed ID: 19463521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis.
    Yokoyama Y; Shimoda T; Shimada YJ; Shimamura J; Akita K; Yasuda R; Takayama H; Kuno T
    Eur J Cardiothorac Surg; 2023 Mar; 63(3):. PubMed ID: 36782361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical septal myectomy or alcohol septal ablation: which approach offers better outcomes for patients with hypertrophic obstructive cardiomyopathy?
    Poon SS; Field M; Gupta D; Cameron D
    Interact Cardiovasc Thorac Surg; 2017 Jun; 24(6):951-961. PubMed ID: 28329292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Survival After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Experience.
    Fernandes V; Karimianpour A; Rier JD; Shaji S; Mullinax BJ; Wahlquist AH; Nielsen CD
    J Invasive Cardiol; 2021 Oct; 33(10):E769-E776. PubMed ID: 34559674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.
    Veselka J; Faber L; Liebregts M; Cooper R; Januska J; Krejci J; Bartel T; Dabrowski M; Hansen PR; Almaas VM; Seggewiss H; Horstkotte D; Adlova R; Bundgaard H; Ten Berg J; Stables RH; Jensen MK
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: technical review and long-term clinical and echocardiographic outcomes.
    Leal S; Galeote G; Jiménez-Valero S; Sánchez-Recalde A; Salinas P; Ruiz AS; Orbe LC; Dominguéz F; Moreno R; López-Sendón JL
    Rev Port Cardiol; 2012 May; 31(5):363-71. PubMed ID: 22482474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.